{"date":"2025-05-23","count":72,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4114-2025-05-23-2016-crol4c","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"20:16:14","subject":"公告本公司第三屆審計委員會名單及第五屆薪酬委員會任期屆滿事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2025-05-23 20:16，「公告本公司第三屆審計委員會名單及第五屆薪酬委員會任期屆滿事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2025-05-23-2015-1ly31ie","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"20:15:39","subject":"公告本公司114年股東常會通過解除本公司新任董事及其代表人競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2025-05-23 20:15，「公告本公司114年股東常會通過解除本公司新任董事及其代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2025-05-23-2015-9769qc","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"20:15:19","subject":"公告本公司董事會選任董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2025-05-23 20:15，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2025-05-23-2014-nlvxew","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"20:14:58","subject":"公告本公司114年股東常會改選董事(含獨立董事)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2025-05-23 20:14，「公告本公司114年股東常會改選董事(含獨立董事)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2025-05-23-2014-ds864w","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"20:14:26","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2025-05-23 20:14，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2025-05-23-1827-1jsy2aq","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"18:27:14","subject":"公告本公司得標「桃園航空城計畫優先產業專用區土地標售案-B基地」(補充公告)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2025-05-23 18:27，「公告本公司得標「桃園航空城計畫優先產業專用區土地標售案-B基地」(補充公告)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-05-23-1751-msbuuq","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"17:51:16","subject":"代重要子公司太景生物科技股份有限公司公告總經理及執行長異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-05-23 17:51，「代重要子公司太景生物科技股份有限公司公告總經理及執行長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-05-23-1750-ceeoyg","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"17:50:45","subject":"公告本公司總經理及執行長異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-05-23 17:50，「公告本公司總經理及執行長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-05-23-1749-1tjohrc","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"17:49:28","subject":"代子公司太景醫藥研發(北京)有限公司公告法人董事改派代表人暨董事變動達三分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-05-23 17:49，「代子公司太景醫藥研發(北京)有限公司公告法人董事改派代表人暨董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-05-23-1747-4h3h5z","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"17:47:46","subject":"代子公司太景生物科技控股(股)有限公司公告法人董事改派代表人暨董事變動達三分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-05-23 17:47，「代子公司太景生物科技控股(股)有限公司公告法人董事改派代表人暨董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-05-23-1745-x44drp","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"17:45:57","subject":"代重要子公司太景生物科技股份有限公司公告董事會代行股東會職權解除董事競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-05-23 17:45，「代重要子公司太景生物科技股份有限公司公告董事會代行股東會職權解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-05-23-1745-lanutp","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"17:45:28","subject":"代重要子公司太景生物科技股份有限公司公告董事長選任案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-05-23 17:45，「代重要子公司太景生物科技股份有限公司公告董事長選任案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2025-05-23-1741-p67uuk","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-23","time":"17:41:15","subject":"公告本公司內部稽核主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-05-23 17:41，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-05-23-1738-u7p5aj","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"17:38:26","subject":"代重要子公司太景生物科技股份有限公司公告法人董事及法人監察人指派代表人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-05-23 17:38，「代重要子公司太景生物科技股份有限公司公告法人董事及法人監察人指派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-05-23-1737-1pdx4zy","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"17:37:10","subject":"公告本公司董事會委任第五屆薪資報酬委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-05-23 17:37，「公告本公司董事會委任第五屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2025-05-23-1737-14qbxjt","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"17:37:09","subject":"代子公司九和生物科技(股)公司公告董事會決議減資","clause":"第11款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2025-05-23 17:37，「代子公司九和生物科技(股)公司公告董事會決議減資」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2025-05-23-1736-g74uyy","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"17:36:51","subject":"代子公司新和生物科技(股)公司公告董事會決議不分配股利","clause":"第14款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2025-05-23 17:36，「代子公司新和生物科技(股)公司公告董事會決議不分配股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2025-05-23-1736-q8qmdk","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"17:36:32","subject":"代子公司九和生物科技(股)公司公告董事會決議分配股利","clause":"第14款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2025-05-23 17:36，「代子公司九和生物科技(股)公司公告董事會決議分配股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-05-23-1736-gviyi0","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"17:36:23","subject":"公告本公司第八屆董事長選任案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-05-23 17:36，「公告本公司第八屆董事長選任案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2025-05-23-1736-1sb5ivn","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"17:36:13","subject":"代子公司東霖儀器(股)公司公告董事會決議分配股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2025-05-23 17:36，「代子公司東霖儀器(股)公司公告董事會決議分配股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2025-05-23-1735-1lw30zy","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"17:35:54","subject":"代子公司醫世紀健康管理顧問(股)公司公告董事會決議分配股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2025-05-23 17:35，「代子公司醫世紀健康管理顧問(股)公司公告董事會決議分配股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2025-05-23-1735-12iu88x","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"17:35:36","subject":"代子公司華霖(股)公司公告董事會決議分配股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2025-05-23 17:35，「代子公司華霖(股)公司公告董事會決議分配股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-05-23-1735-za3byx","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"17:35:29","subject":"公告本公司第四屆審計委員會委員名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-05-23 17:35，「公告本公司第四屆審計委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2025-05-23-1735-1jew7bo","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"17:35:19","subject":"代子公司九和科技(股)公司公告董事會決議分配股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2025-05-23 17:35，「代子公司九和科技(股)公司公告董事會決議分配股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2025-05-23-1735-1eilj9q","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"17:35:01","subject":"代子公司多模式(股)公司公告董事會決議分配股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2025-05-23 17:35，「代子公司多模式(股)公司公告董事會決議分配股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2025-05-23-1734-10ybqwd","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"17:34:43","subject":"代重要子公司杏業生技(股)公司公告董事會決議分配股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2025-05-23 17:34，「代重要子公司杏業生技(股)公司公告董事會決議分配股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2025-05-23-1734-132muta","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"17:34:22","subject":"代重要子公司久和醫療儀器(股)公司公告董事會決議分配股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2025-05-23 17:34，「代重要子公司久和醫療儀器(股)公司公告董事會決議分配股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-05-23-1734-1099cwf","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"17:34:21","subject":"公告本公司114年度股東常會通過解除新任第八屆董事及其代表人競業禁止之限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-05-23 17:34，「公告本公司114年度股東常會通過解除新任第八屆董事及其代表人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-05-23-1733-llp381","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"17:33:17","subject":"公告本公司114年股東常會全面改選董事","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-05-23 17:33，「公告本公司114年股東常會全面改選董事」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2025-05-23-1726-1nqrady","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"17:26:01","subject":"代重要子公司棉花田生機園地(股)公司公告114年股東常會決議解除董事競業禁止之限制事宜","clause":"第21款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：中天（4128），2025-05-23 17:26，「代重要子公司棉花田生機園地(股)公司公告114年股東常會決議解除董事競業禁止之限制事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6483-2025-05-23-1719-68uxe4","company_id":"6483","company":"原創生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-23","time":"17:19:21","subject":"公告本公司收到「用於上呼吸道給藥之組成物及其給藥方法」之中國專利核准通知書","clause":"第44款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：原創生醫（6483），2025-05-23 17:19，「公告本公司收到「用於上呼吸道給藥之組成物及其給藥方法」之中國專利核准通知書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-05-23-1719-d9bwy4","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"17:19:17","subject":"公告本公司114年度股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-05-23 17:19，「公告本公司114年度股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2025-05-23-1719-11ra86q","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2025-05-23","time":"17:19:08","subject":"本公司受邀參加台新證券舉辦之興櫃前法人說明會","clause":"第9款","fact_date":"2025-05-26","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2025-05-23 17:19，「本公司受邀參加台新證券舉辦之興櫃前法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2025-05-23-1719-1oe79nr","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"17:19:07","subject":"代重要子公司棉花田生機園地(股)公司公告114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：中天（4128），2025-05-23 17:19，「代重要子公司棉花田生機園地(股)公司公告114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2025-05-23-1714-jnf97a","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"17:14:12","subject":"公告本公司114年股東常會重要決議事項。","clause":"第18款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2025-05-23 17:14，「公告本公司114年股東常會重要決議事項。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2025-05-23-1704-34ha9q","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"17:04:01","subject":"公告本公司現金股利發放公告","clause":"第14款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2025-05-23 17:04，「公告本公司現金股利發放公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2025-05-23-1703-qmpqzy","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"17:03:32","subject":"開發中新藥OBP-301進度更新","clause":"第53款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2025-05-23 17:03，「開發中新藥OBP-301進度更新」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-05-23-1657-1de4yg8","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"16:57:33","subject":"公告本公司員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-05-23 16:57，「公告本公司員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-05-23-1657-x1ohmw","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"16:57:13","subject":"公告本公司限制員工權利新股增資基準日相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-05-23 16:57，「公告本公司限制員工權利新股增資基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2025-05-23-1646-lvmhu7","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"16:46:47","subject":"公告本公司第五屆薪資報酬委員會委員任期屆滿","clause":"第6款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2025-05-23 16:46，「公告本公司第五屆薪資報酬委員會委員任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2025-05-23-1646-fcqtbl","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"16:46:29","subject":"公告本公司審計委員會委員任期屆滿異動","clause":"第6款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2025-05-23 16:46，「公告本公司審計委員會委員任期屆滿異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2025-05-23-1646-fv20ps","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"16:46:12","subject":"公告本公司董事會推選張立秋先生續任董事長","clause":"第6款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2025-05-23 16:46，「公告本公司董事會推選張立秋先生續任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2025-05-23-1645-1g85mfy","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"16:45:53","subject":"公告本公司股東常會通過解除新任董事及其代表人競業禁止之限制","clause":"第21款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2025-05-23 16:45，「公告本公司股東常會通過解除新任董事及其代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2025-05-23-1645-bbdt5u","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"16:45:33","subject":"公告本公司114年股東常會全面改選董事(含獨立董事)","clause":"第6款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2025-05-23 16:45，「公告本公司114年股東常會全面改選董事(含獨立董事)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2025-05-23-1645-ds864w","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"16:45:08","subject":"公告本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2025-05-23 16:45，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4102-2025-05-23-1637-1287lm","company_id":"4102","company":"永日","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"16:37:50","subject":"代重要子公司台灣味群工業股份有限公司公告114年股東會重要決議事項","clause":"第18款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：永日（4102），2025-05-23 16:37，「代重要子公司台灣味群工業股份有限公司公告114年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2025-05-23-1637-14zhoum","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"16:37:45","subject":"公告本公司114年股東常會通過解除董事競業禁止之限制案","clause":"第21款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2025-05-23 16:37，「公告本公司114年股東常會通過解除董事競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2025-05-23-1637-t6rqxo","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"16:37:09","subject":"公告本公司114年股東常會重要決議","clause":"第18款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2025-05-23 16:37，「公告本公司114年股東常會重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-05-23-1546-9envtv","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"15:46:45","subject":"代重要子公司意能生技股份有限公司公告董事會推選張有德先生續任董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-05-23 15:46，「代重要子公司意能生技股份有限公司公告董事會推選張有德先生續任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1733-2025-05-23-1542-qcx1gh","company_id":"1733","company":"五鼎","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"15:42:15","subject":"公告本公司決議除息基準日","clause":"第14款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：五鼎（1733），2025-05-23 15:42，「公告本公司決議除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-05-23-1541-b2qnai","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"15:41:16","subject":"代本公司重要子公司意能生技股份有限公司公告114年股東常會通過解除董事及其代表人競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-05-23 15:41，「代本公司重要子公司意能生技股份有限公司公告114年股東常會通過解除董事及其代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1733-2025-05-23-1538-ds864w","company_id":"1733","company":"五鼎","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"15:38:26","subject":"公告本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：五鼎（1733），2025-05-23 15:38，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2025-05-23-1537-1ap8fql","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"15:37:03","subject":"公告本公司註銷收回之限制員工權利新股辦理減資變更登記完成","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2025-05-23 15:37，「公告本公司註銷收回之限制員工權利新股辦理減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2025-05-23-1531-p67uuk","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"15:31:53","subject":"公告本公司內部稽核主管異動","clause":"第11款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2025-05-23 15:31，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6973-2025-05-23-1530-1ryer4r","company_id":"6973","company":"永立榮","market":"興櫃","industry":"生技醫療","date":"2025-05-23","time":"15:30:09","subject":"公告本公司買回庫藏股已執行完畢事宜","clause":"第41款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：永立榮（6973），2025-05-23 15:30，「公告本公司買回庫藏股已執行完畢事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-05-23-1529-t7kewa","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"15:29:04","subject":"代重要子公司意能生技股份有限公司公告114年股東常會董事及監察人當選名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-05-23 15:29，「代重要子公司意能生技股份有限公司公告114年股東常會董事及監察人當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-05-23-1512-hxi0rj","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"15:12:28","subject":"代重要子公司意能生技股份有限公司公告114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-05-23 15:12，「代重要子公司意能生技股份有限公司公告114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-05-23-1506-3xijz5","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"15:06:16","subject":"代重要子公司益興生醫股份有限公司公告2025年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-05-23 15:06，「代重要子公司益興生醫股份有限公司公告2025年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2025-05-23-1505-12t02f3","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"15:05:50","subject":"公告本公司第四屆薪資報酬委員會委員","clause":"第6款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：華安（6657），2025-05-23 15:05，「公告本公司第四屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2025-05-23-1502-1qv4g4g","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"15:02:53","subject":"公告本公司第三屆審計委員會名單","clause":"第6款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：華安（6657），2025-05-23 15:02，「公告本公司第三屆審計委員會名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2025-05-23-1501-1eecwz8","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2025-05-23","time":"15:01:11","subject":"本公司研發中新藥ABT-101台灣Phase Ib臨床試驗用以評估於晚期實體腫瘤患者之安全性與耐受性試驗結果。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2025-05-23 15:01，「本公司研發中新藥ABT-101台灣Phase Ib臨床試驗用以評估於晚期實體腫瘤患者之安全性與耐受性試驗結果。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2025-05-23-1500-1m17pam","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"15:00:26","subject":"公告本公司董事會選任董事長及副董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華安（6657），2025-05-23 15:00，「公告本公司董事會選任董事長及副董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2025-05-23-1457-w4l0am","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"14:57:57","subject":"公告本公司股東常會決議通過解除董事競業禁止之限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華安（6657），2025-05-23 14:57，「公告本公司股東常會決議通過解除董事競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2025-05-23-1450-nlvxew","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"14:50:07","subject":"公告本公司114年股東常會改選董事(含獨立董事)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華安（6657），2025-05-23 14:50，「公告本公司114年股東常會改選董事(含獨立董事)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2025-05-23-1445-ds864w","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2025-05-23","time":"14:45:10","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華安（6657），2025-05-23 14:45，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4162-2025-05-23-1424-17vkp6y","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"14:24:55","subject":"公告本公司董事會委任薪資報酬委員會委員","clause":"第6款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2025-05-23 14:24，「公告本公司董事會委任薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4162-2025-05-23-1423-te481f","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"14:23:56","subject":"公告本公司董事會委任審計委員會委員","clause":"第6款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2025-05-23 14:23，「公告本公司董事會委任審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4162-2025-05-23-1423-kin0xg","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"14:23:24","subject":"公告本公司新任董事長事宜","clause":"第6款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2025-05-23 14:23，「公告本公司新任董事長事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4162-2025-05-23-1423-qn0306","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"14:23:11","subject":"公告本公司股東會通過解除董事競業禁止之限制","clause":"第21款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2025-05-23 14:23，「公告本公司股東會通過解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4162-2025-05-23-1422-13rqcss","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"14:22:46","subject":"公告本公司114年股東常會全面改選董事9席(含獨立董事3席)","clause":"第6款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2025-05-23 14:22，「公告本公司114年股東常會全面改選董事9席(含獨立董事3席)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4162-2025-05-23-1422-ds864w","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"14:22:30","subject":"公告本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-05-23","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2025-05-23 14:22，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2025-05-23-1338-1xnu34j","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2025-05-23","time":"13:38:37","subject":"本公司受邀參加櫃買中心業績發表會","clause":"第12款","fact_date":"2025-05-26","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2025-05-23 13:38，「本公司受邀參加櫃買中心業績發表會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}